Showing results (251-260 of 266) with videos related to
Sort By:
Pageof 27
Oncology Letters|November 24, 2022
Gene panel testing detects important genetic alterations in ulcerative colitis-associated colorectal neoplasiaYoshifumi Shimada, Mae Nakano, Ken-Ichi Mizuno, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 17, 2020
[A Case of High-Frequency Microsatellite Instability in Colorectal Cancer with MSH2 Mutation Detected Using Gene Panel Testing with a Next-Generation Sequencer]Yoshifumi Shimada, Hitoshi Kameyama, Mae Nakano, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 16, 2021
[Laparoscopic Abdominoperineal Resection after Preoperative Chemoradiotherapy for Adenocarcinoma Associated with Anal Fistula]Kana Tanaka, Mae Nakano, Yoshifumi Shimada, et al.BMC Surgery|December 14, 2022
Conversion surgery for stage IV gastric cancer: a multicenter retrospective studyYosuke Kano, Hiroshi Ichikawa, Takaaki Hanyu, et al.Cancers|July 12, 2025
Discordance Between Radiological and Pathological Responses to Pembrolizumab in Mismatch Repair-Deficient Metastatic Colorectal Cancer: Implications for Precision OncologyYoshifumi Shimada, Mae Nakano, Akio Matsumoto, et al.Journal of Gynecologic Oncology|December 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancerAikou Okamoto, Eiji Kondo, Toshiaki Nakamura, et al.Genome Medicine|November 2, 2017
Actionable gene-based classification toward precision medicine in gastric cancerHiroshi Ichikawa, Masayuki Nagahashi, Yoshifumi Shimada, et al.Journal of Gynecologic Oncology|September 9, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 studyDaisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, et al.Journal of Gastroenterology|April 12, 2026
Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine-cisplatin in advanced biliary tract cancer: a multicenter real-world studyHisashi Kosaka, Rie Sugimoto, Masahiko Kinoshita, et al.Human Pathology|February 26, 2017
Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancerYoshifumi Shimada, Ryoma Yagi, Hitoshi Kameyama, et al.Pageof 27